These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 5294176)

  • 1. A controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in the Philippines. Preliminary report; Philippines Cholera Committee.
    Philippines Cholera Committee
    Bull World Health Organ; 1965; 32(5):603-25. PubMed ID: 5294176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in the Philippines.
    Azurin JC; Cruz A; Pesigan TP; Alvero M; Camena T; Suplido R; Ledesma L; Gomez CZ
    Bull World Health Organ; 1967; 37(5):703-27. PubMed ID: 5300874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled field trial of the effectiveness of monovalent classical and El Tor cholera vaccines in the Philippines.
    Philippines Cholera Committee
    Bull World Health Organ; 1973; 49(1):13-9. PubMed ID: 4596491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled field trial of the effectiveness of various doses of cholera El Tor vaccine in the Philippines.
    Philippines Cholera Committee
    Bull World Health Organ; 1968; 38(6):917-23. PubMed ID: 5303665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in Calcutta.
    Das Gupta A; Sinha R; Shrivastava DL; De SP; Taneja BL; Rao MS; Abou-Gareeb AH
    Bull World Health Organ; 1967; 37(3):371-85. PubMed ID: 5301381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled field trial on the effectiveness of the intradermal and subcutaneous administration of cholera vaccine in the Philippines.
    Philippines Cholera Committee
    Bull World Health Organ; 1973; 49(4):389-94. PubMed ID: 4603994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholera incidence in a population offered cholera vaccination: comparison of cooperative and uncooperative groups.
    Azurin JC; Alvero M
    Bull World Health Organ; 1971; 44(6):815-9. PubMed ID: 4950563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholera vaccine field trials in east Pakistan. 2. Effectiveness in the field.
    Benenson AS; Mosley WH; Fahimuddin M; Oseasohn RO
    Bull World Health Organ; 1968; 38(3):359-72. PubMed ID: 5302329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled field trial of plain and aluminium hydroxide-adsorbed cholera vaccines in Surabaya, Indonesia, during 1973--75.
    Saroso JS; Bahrawi W; Witjaksono H; Budiarso RL; Brotowasisto ; Bencić Z; Dewitt WE; Gomez CZ
    Bull World Health Organ; 1978; 56(4):619-27. PubMed ID: 365388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam.
    Trach DD; Clemens JD; Ke NT; Thuy HT; Son ND; Canh DG; Hang PV; Rao MR
    Lancet; 1997 Jan; 349(9047):231-5. PubMed ID: 9014909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral vaccines for cholera control.
    Chaturvedi S; Chaturvedi S
    Natl Med J India; 1997; 10(1):17-8. PubMed ID: 9069701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of mass oral cholera vaccination in Beira, Mozambique.
    Lucas ME; Deen JL; von Seidlein L; Wang XY; Ampuero J; Puri M; Ali M; Ansaruzzaman M; Amos J; Macuamule A; Cavailler P; Guerin PJ; Mahoudeau C; Kahozi-Sangwa P; Chaignat CL; Barreto A; Songane FF; Clemens JD
    N Engl J Med; 2005 Feb; 352(8):757-67. PubMed ID: 15728808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Field trials of monovalent Ogawa and Inaba cholera vaccines in rural Bangladesh--three years of observation.
    Mosley WH; Aziz KM; Rahman AS; Chowdhury AK; Ahmed A
    Bull World Health Organ; 1973; 49(4):381-7. PubMed ID: 4604478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera.
    Murray J; McFarland DA; Waldman RJ
    Bull World Health Organ; 1998; 76(4):343-52. PubMed ID: 9803585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of cholera El Tor in the Philippines. I. Characteristics of cholera El Tor in Negros Occidental Province, November 1961 to September 1962.
    Dizon JJ; Alvero MG; Joseph PR; Tamayo JF; Mosley WH; Henderson DA
    Bull World Health Organ; 1965; 33(5):627-36. PubMed ID: 5295143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Peru-15 (CholeraGarde), a live-attenuated oral cholera vaccine: 1991-2009.
    Chowdhury MI; Sheikh A; Qadri F
    Expert Rev Vaccines; 2009 Dec; 8(12):1643-52. PubMed ID: 19943759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate.
    Levine MM; Black RE; Clements ML; Young CR; Lanata C; Sears S; Honda T; Finkelstein R
    Dev Biol Stand; 1983; 53():59-65. PubMed ID: 6873477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current problems of epidemiology and prevention of El Tor cholera].
    Teodorovici G
    Rev Med Chir Soc Med Nat Iasi; 1971; 75(1):1-7. PubMed ID: 5552559
    [No Abstract]   [Full Text] [Related]  

  • 20. Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru.
    Taylor DN; Cárdenas V; Sanchez JL; Bégué RE; Gilman R; Bautista C; Perez J; Puga R; Gaillour A; Meza R; Echeverria P; Sadoff J
    J Infect Dis; 2000 May; 181(5):1667-73. PubMed ID: 10823767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.